Literature DB >> 20478489

Management of gallbladder cancer.

Shiva Jayaraman1, William R Jarnagin.   

Abstract

Resection is a means of improving survival in patients with gallbladder cancer. A more aggressive surgical approach, including resection of the gallbladder, liver, and regional lymph nodes, is advisable for patients with T1b to T4 tumors. Aggressive resection is necessary because a patient's gallbladder cancer stage determines the outcome, not the surgery itself. Therefore, major resections should be offered to appropriately selected patients. Patients with advanced tumors or metastatic disease are not candidates for radical resection and thus should be directed to more suitable palliation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20478489     DOI: 10.1016/j.gtc.2010.02.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  36 in total

Review 1.  Gallbladder cancer.

Authors:  Mislav Rakić; Leonardo Patrlj; Mario Kopljar; Robert Kliček; Marijan Kolovrat; Bozo Loncar; Zeljko Busic
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.

Authors:  Wenjun Wang; Zhu-lin Yang; Jie-qiong Liu; Song Jiang; Xiong-ying Miao
Journal:  Tumour Biol       Date:  2011-11-12

3.  Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma.

Authors:  Kyungeun Kim; Dong-Hoon Kim; Seoung Wan Chae; Jun-Ho Shin; Hong Joo Kim; Sung-Im Do; Hyun Joo Lee; Ji Hae Koo; Jung-Soo Pyo; Jin Hee Sohn
Journal:  Pathol Oncol Res       Date:  2013-11-01       Impact factor: 3.201

4.  ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.

Authors:  Jianning Sun; Zhu-Lin Yang; Xiongying Miao; Qiong Zou; Jinghe Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  J Mol Histol       Date:  2014-10-14       Impact factor: 2.611

5.  Clinical, pathological and sonographic characteristics of unexpected gallbladder carcinoma.

Authors:  Jin-Huan Wang; Bo-Ji Liu; Hui-Xiong Xu; Li-Ping Sun; Dan-Dan Li; Le-Hang Guo; Lin-Na Liu; Xiao-Hong Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

Authors:  J Li; Z Yang; Q Zou; Y Yuan; J Li; L Liang; G Zeng; S Chen
Journal:  Clin Transl Oncol       Date:  2013-06-21       Impact factor: 3.405

7.  Squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder: an immunohistochemistry study of prognostic markers.

Authors:  Jiequn Li; Zhu-Lin Yang; Qiong Zou; Yuan Yuan; Jinghe Li; Lufeng Liang; Guixiang Zhen; Senlin Chen
Journal:  Pathol Oncol Res       Date:  2013-09-28       Impact factor: 3.201

8.  ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Jinghe Li; Zhu-Lin Yang; Xuebao Ren; Qiong Zou; Yuan Yuan; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Tumour Biol       Date:  2012-10-13

9.  A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.

Authors:  Zhulin Yang; Zhi Yang; Qiong Zou; Yuan Yuan; Jinghe Li; Daiqiang Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

10.  Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Xiongying Miao; Zhu-Lin Yang; Li Xiong; Qiong Zou; Yuan Yuan; Jinghe Li; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.